Toggle Main Menu Toggle Search

Open Access padlockePrints

Activation of the pro-drug ethionamide is regulated in mycobacteria

Lookup NU author(s): Joanne Betts, Professor Del Besra

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

The anti-tuberculosis drug ethionamide (ETH), which is a structural analog of isoniazid (INH), is known to strongly inhibit mycolic acid synthesis in Mycobacterium tuberculosis. Although several targets have been identified for INH, only speculative information is available concerning ETH. Mutations within the promoter and the coding region of enoyl-acyl carrier protein reductase (InhA) were found to confer resistance to both drugs, thus leading to the impression that INH and ETH may share a common mode of action. However, a notable distinction between the two drugs lies in the lack of cross-resistance in clinical isolates. This may be attributed in part to the fact that the pro-drug INH must be activated via KatG, and no activation step for ETH has yet been described. Here we report the identification of an activator for ETH. The ETH activator (Rv3854c), which we have termed EthA, was found to be homologous to various monooxygenases and induced ETH sensitivity when overexpressed in mycobacteria. Interestingly, the neighboring open reading flame (Rv3855), which was found homologous to transcriptional repressors of the tetR family, led to ETH resistance when over-expressed. In addition, chromosomal inactivation of this gene by transposition led to ETH hypersensitivity. These data strongly suggest that Rv3855, which we have termed EthR, regulates the production of EthA, which subsequently activates the pro-drug ETH. This study opens up new avenues of research relating to ETH activation in mycobacteria, possibly leading to an improved efficacy of ETH and to the generation of new anti-mycobacterial agents.


Publication metadata

Author(s): Baulard AR, Betts JC, Engohang-Ndong J, Quan S, McAdam RA, Brennan PJ, Locht C, Besra GS

Publication type: Article

Publication status: Published

Journal: Journal of Biological Chemistry

Year: 2000

Volume: 275

Issue: 36

Pages: 28326-28331

ISSN (print): 0021-9258

ISSN (electronic): 1083-351X

Publisher: American Society for Biochemistry and Molecular Biology

URL: http://dx.doi.org/10.1074/jbc.M003744200

DOI: 10.1074/jbc.M003744200

PubMed id: 10869356


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
AI-18357NIAID NIH HHS
AI-33706NIAID NIH HHS
AI-38087NIAID NIH HHS

Share